This inventor holds 1 USPTO granted patent. Top assignee: Exact Sciences Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Mikkel Noerholm: Innovator in Extracellular Vesicle Isolation
Introduction
Mikkel Noerholm is a notable inventor based in Martinsried, Germany. He has made significant contributions to the field of biotechnology, particularly in the isolation of extracellular vesicles and cell-free DNA from biofluids. His innovative work has the potential to advance research and clinical applications in various medical fields.
Latest Patents
Mikkel Noerholm holds a patent for "Automated and manual methods for isolation of extracellular vesicles and co-isolation of cell-free DNA from biofluids." This invention provides novel methods and kits for a fully automated high-throughput approach to isolate extracellular vesicles and co-isolate cell-free DNA from biofluids. The methods do not require the use of phenol or chloroform, making them safer and more efficient for extracting nucleic acids from biological samples.
Career Highlights
Mikkel Noerholm is currently associated with Exact Sciences Corporation, where he continues to develop innovative solutions in the field of molecular diagnostics. His work focuses on enhancing the efficiency and safety of biological sample processing, which is crucial for advancing medical research and diagnostics.
Collaborations
Mikkel collaborates with talented professionals in his field, including Georg Stoll and Daniel Enderle. These collaborations foster a creative environment that drives innovation and enhances the development of new technologies.
Conclusion
Mikkel Noerholm's contributions to the field of biotechnology, particularly through his patented methods for isolating extracellular vesicles and cell-free DNA, highlight his role as a leading inventor. His work at Exact Sciences Corporation and collaborations with other experts underscore the importance of innovation in advancing medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
